Ballard’s revived preschool plan takes big step forward
Indianapolis appears to be on its way to launching a $40 million preschool program to serve the city’s poorest children.
Indianapolis appears to be on its way to launching a $40 million preschool program to serve the city’s poorest children.
Mayor Greg Ballard may have begun his tenure as Indy’s top elected official with the label “accidental mayor.” But Ballard’s legacy will go well beyond the circumstances of his upset victory in 2007.
The results have immediate implications for 1 million Americans who suffer mild heart attacks or chest pain each year. They may also make it easier for other experimental medicines from companies such as Eli Lilly to reach patients.
The money is designed to further the life sciences group’s work on such initiatives as the Indiana Biosciences Research Institute and the Indiana Health Information Exchange.
Derica Rice, CFO at Eli Lilly and Co., held a host of positions with the pharmaceutical giant before taking over as CFO of the entire operation in 2006.
The health care industry has announced about $438 billion worth of mergers and acquisitions worldwide so far in 2014, about 14 percent of the $3.2 trillion total for all industries.
Prosecutors say the theft from an Eli Lilly and Co. warehouse in Connecticut involved up to $100 million in prescription drugs.
A major drugmaker that was part of three-way multi-billion-dollar deal this year involving Eli Lilly and Co. is planning a reorganization that will include hundreds of job cuts in the United States.
Indianapolis-based PTS Diagnostics is on pace to boost revenue 60 percent this year, fueled by its acquisition of a blood glucose test and a shift to help doctors and nurses do a better job monitoring the health of their patients. PTS acquired the A1C Now test in December 2013 from Germany-based Bayer AG. That product […]
The life insurer is renovating 10 of the floors it occupies in its namesake building downtown and is removing the outdated and constrictive cubicles for a more modern, open floor plan.
Eli Lilly and Co. said Tuesday it will team up with Zosano Pharma Corp. on an experimental osteoporosis patch in a deal that could be worth more than $440 million.
Biogen Idec Inc. shares rose Tuesday after the company said its Alzheimer’s drug showed promising early results and will be quickly moved into a final-stage trial.
Claire Fiddian-Green led the Center for Career & Education Innovation, which Gov. Mike Pence said he would dissolve to “restore harmony and trust” with Glenda Ritz, the superintendent of public instruction.
Federal prosecutors dropped all charges against two scientists accused of stealing trade secrets worth $55 million from Eli Lilly and Co. after new information emerged last month, according to a court motion made Friday.
People listings are free, but it becomes a paid feature beginning Jan. 1.
William G. Mays, who built one of the nation's largest minority-owned companies and saved one of its oldest African-American newspapers, died Thursday in Indianapolis on his 69th birthday. “Indianapolis has lost a titan of industry and philanthropy,” Mayor Greg Ballard said.
Avanir Pharmaceuticals Inc. has reached a The Aliso Viejo, California-based company, which makes a drug to control symptoms of Alzheimer’s disease, this week agreed to sell itself to Japan’s Otsuka Holdings Co. for $3.2 billion, or $17 a share. That’s 4 percent lower than analysts’ average projection for where the stock would have traded in […]
Indianapolis Symphony Orchestra's leaders played an upbeat tune Monday, reporting a second-consecutive operating surplus fueled by a 16-percent increase in revenue from ticket sales and a near-record year for fundraising.
Indianapolis hospital leaders have spent the past two months ironing out a plan to deal with any cases of Ebola that emerge in Indiana. The plan is aimed at ensuring effective care while minimizing the need to bring other hospital services to a virtual halt while patients are under care. Eskenazi Hospital, St. Vincent Indianapolis […]
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.